Thymidylate Kinase-Targeted Antimicrobial Peptides via Phage Display: A Novel Strategy against Gram-Negative Bacteria
Journal of Medicinal Chemistry · 13.03.2025 · 68 (5) · 5488-5502
DOI: 10.1021/acs.jmedchem.4c02666 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 25.02.2025. Verfasst von Mingyang Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Nutrition and Immunity, College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, People's …. Hauptthemen laut MEDLINE: Nucleoside-Phosphate Kinase, Microbial Sensitivity Tests, Anti-Bacterial Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Northeast Agricultural University, National Natural Science Foundation of China.
Abstract (Originalsprache)
The rise of antimicrobial resistance (AMR) in Gram-negative bacteria, including Escherichia coli (E. coli), poses a major public health threat. This study aimed to address the limitations of existing antimicrobial peptides (AMPs) by designing hybrid peptides with enhanced targeting and antibacterial potency. Eight heptapeptide sequences were identified through phage display screening and hybridized with WP (WKKIWKPGIKKWIK), a peptide exhibiting weak antimicrobial activity against Gram-negative bacteria. The hybrid peptides were systematically evaluated for their antimicrobial activity, specificity, and biocompatibility. The hybrid peptide SWP exhibited superior antibacterial activity, particularly against E. coli K88 (TI = 2.378), and demonstrated specific binding to thymidylate kinase (TMK), a key bacterial enzyme. In vivo studies employing a mouse peritonitis model confirmed SWP's ability to reduce bacterial loads and mitigate tissue damage while maintaining excellent biocompatibility. These findings underscore SWP as a promising candidate for the development of targeted antimicrobial agents with enhanced specificity and stability for Gram-negative pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Nutrition and Immunity, College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, People's Republic of China.
ORCID-Profile: Na Dong
Förderung
- National Key Research and Development Program of China
- Northeast Agricultural University
- National Natural Science Foundation of China
- Earmarked Fund for China Agriculture Research System
- Science Fund for Distinguished Young Scholars of Heilongjiang Province
Zitieren
APA
Hu, M., Li, Y., Zhao, L., Cha, S., Fang, Y., Xue, C., & Dong, N. (2025). Thymidylate Kinase-Targeted Antimicrobial Peptides via Phage Display: A Novel Strategy against Gram-Negative Bacteria. Journal of Medicinal Chemistry, 68(5), 5488-5502. https://doi.org/10.1021/acs.jmedchem.4c02666
Vancouver
Hu M, Li Y, Zhao L, Cha S, Fang Y, Xue C, et al. Thymidylate Kinase-Targeted Antimicrobial Peptides via Phage Display: A Novel Strategy against Gram-Negative Bacteria. Journal of Medicinal Chemistry. 2025;68(5):5488-5502. doi:10.1021/acs.jmedchem.4c02666
BibTeX
@article{Hu2025,
author = {Hu, Mingyang and Li, Yuwen and Zhao, Lu and Cha, Sina and Fang, Yuxin and Xue, Chenyu and Dong, Na},
title = {Thymidylate Kinase-Targeted Antimicrobial Peptides via Phage Display: A Novel Strategy against Gram-Negative Bacteria},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {5},
pages = {5488--5502},
doi = {10.1021/acs.jmedchem.4c02666}
}
EUVIMED